Search Results

There are 10180 results for: content related to: Long-term follow-up of peginterferon and lamivudine combination treatment in HBeAg-positive chronic hepatitis B

  1. Lamivudine salts with improved solubilities

    Journal of Pharmaceutical Sciences

    Volume 101, Issue 6, June 2012, Pages: 2143–2154, Felipe T. Martins, Rudy Bonfilio, Magali B. De Araújo and Javier Ellena

    Version of Record online : 14 MAR 2012, DOI: 10.1002/jps.23117

  2. You have free access to this content
    JSH Guidelines for the Management of Hepatitis B Virus Infection

    Hepatology Research

    Volume 44, Issue S1, January 2014, Pages: 1–58, Drafting Committee for Hepatitis Management Guidelines and the Japan Society of Hepatology

    Version of Record online : 7 JAN 2014, DOI: 10.1111/hepr.12269

  3. You have free access to this content
    Chronic hepatitis B

    Hepatology

    Volume 45, Issue 2, February 2007, Pages: 507–539, Anna S. F. Lok and Brian J. McMahon

    Version of Record online : 26 JAN 2007, DOI: 10.1002/hep.21513

  4. Management of viral hepatitis B

    Journal of Gastroenterology and Hepatology

    Volume 17, Issue s1, February 2002, Pages: S125–S145, CHUTIMA PRAMOOLSINSUP

    Version of Record online : 8 MAY 2002, DOI: 10.1046/j.1440-1746.17.s1.3.x

  5. You have free access to this content
    Lamivudine plus interleukin-12 combination therapy in chronic hepatitis B: Antiviral and immunological activity

    Hepatology

    Volume 42, Issue 5, November 2005, Pages: 1028–1036, Eirini I. Rigopoulou, Deepak Suri, Shilpa Chokshi, Ivana Mullerova, Steven Rice, Richard S. Tedder, Roger Williams and Nikolai V. Naoumov

    Version of Record online : 25 OCT 2005, DOI: 10.1002/hep.20888

  6. Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2005 update

    Liver International

    Volume 25, Issue 3, June 2005, Pages: 472–489, Yun-Fan Liaw, Nancy Leung, Richard Guan, George K.K. Lau, Ismail Merican, Geoff McCaughan, Edward Gane, Jia-Horng Kao, Masao Omata and for the Asian-Pacific consensus update working party on chronic hepatitis B

    Version of Record online : 21 MAY 2005, DOI: 10.1111/j.1478-3231.2005.01134.x

  7. You have free access to this content
    Systematic review: combination therapies for treatment-naïve chronic hepatitis B

    Alimentary Pharmacology & Therapeutics

    Volume 27, Issue 12, June 2008, Pages: 1187–1209, M. KUMAR and S. K. SARIN

    Version of Record online : 28 MAR 2008, DOI: 10.1111/j.1365-2036.2008.03695.x

  8. Efficacy of switching to telbivudine in chronic hepatitis B patients treated previously with lamivudine

    Liver International

    Volume 31, Issue 5, May 2011, Pages: 667–675, Rifaat Safadi, Qing Xie, Yagang Chen, You-Kuan Yin, Lai Wei, Seong Gyu Hwang, Eli Zuckerman, Ji-Dong Jia and Patricia Lopez

    Version of Record online : 29 OCT 2010, DOI: 10.1111/j.1478-3231.2010.02360.x

  9. Should lamivudine monotherapy be stopped or continued in patients infected with hepatitis B with favorable responses after more than 5 years of treatment?

    Journal of Medical Virology

    Volume 85, Issue 1, January 2013, Pages: 34–42, Jung Hyun Kwon, Jeong Won Jang, Jong Young Choi, Chung-Hwa Park, Sun Hong Yoo, Si Hyun Bae and Seung Kew Yoon

    Version of Record online : 14 NOV 2012, DOI: 10.1002/jmv.23421

  10. Efficacy of switching to entecavir monotherapy in Japanese lamivudine-pretreated patients

    Journal of Gastroenterology and Hepatology

    Volume 25, Issue 5, May 2010, Pages: 892–898, Fumitaka Suzuki, Norio Akuta, Yoshiyuki Suzuki, Hiromi Yatsuji, Hitomi Sezaki, Yasuji Arase, Miharu Hirakawa, Yusuke Kawamura, Tetsuya Hosaka, Masahiro Kobayashi, Satoshi Saitoh, Kenji Ikeda, Mariko Kobayashi, Sachiyo Watahiki and Hiromitsu Kumada

    Version of Record online : 30 OCT 2009, DOI: 10.1111/j.1440-1746.2009.06161.x

  11. Management of chronic hepatitis B virus infection: a new era of disease control

    Internal Medicine Journal

    Volume 36, Issue 2, February 2006, Pages: 100–113, G. C. Farrell and N. C. Teoh

    Version of Record online : 10 FEB 2006, DOI: 10.1111/j.1445-5994.2006.01027.x

  12. Treatment of chronic hepatitis B

    Journal of Viral Hepatitis

    Volume 12, Issue 4, July 2005, Pages: 333–345, P. Marcellin, T. Asselah and N. Boyer

    Version of Record online : 28 JUN 2005, DOI: 10.1111/j.1365-2893.2005.00599.x

  13. You have free access to this content
    Prophylaxis against de novo hepatitis B for liver transplantation utilizing hep B core (+) donors: does hepatitis B immunoglobulin provide a survival advantage?

    Transplant International

    Volume 24, Issue 6, June 2011, Pages: 570–581, Guy N. Brock, Farida Mostajabi, Nicole Ferguson, Christopher J. Carrubba, Mary Eng, Joseph F. Buell and Michael R. Marvin

    Version of Record online : 15 MAR 2011, DOI: 10.1111/j.1432-2277.2011.01236.x

  14. Lamivudine or adefovir dipivoxil alone or combined with immunoglobulin for preventing hepatitis B recurrence after liver transplantation

    Intervention Review

    The Cochrane Library

    Lior H Katz, Ran Tur-Kaspa, Daniel G Guy and Mical Paul

    Published Online : 7 JUL 2010, DOI: 10.1002/14651858.CD006005.pub2

  15. You have free access to this content
    Predictors of HBeAg loss after lamivudine treatment for chronic hepatitis B

    Hepatology

    Volume 36, Issue 1, July 2002, Pages: 186–194, Robert P. Perrillo, Ching-Lung Lai, Yun-Fan Liaw, Jules L. Dienstag, Eugene R. Schiff, Solko W. Schalm, E. Jenny Heathcote, Nathaniel A. Brown, Mark Atkins, Mary Woessner and Stephen D. Gardner

    Version of Record online : 30 DEC 2003, DOI: 10.1053/jhep.2002.34294

  16. You have free access to this content
    AASLD Abstracts 895–1142

    Hepatology

    Volume 48, Issue S1, October 2008, Pages: 707A–816A,

    Version of Record online : 24 SEP 2008, DOI: 10.1002/hep.22644

  17. Treatment of chronic hepatitis B with the combination of pegylated interferon with lamivudine

    Hepatology Research

    Volume 37, Issue s1, July 2007, Pages: S55–S61, Patrick Marcellin, Olivier Lada and Tarik Asselah

    Version of Record online : 9 JUL 2007, DOI: 10.1111/j.1872-034X.2007.00106.x

  18. Clinical outcomes of chronic hepatitis B patients with persistently detectable serum hepatitis B virus DNA during lamivudine therapy

    Journal of Gastroenterology and Hepatology

    Volume 22, Issue 8, August 2007, Pages: 1220–1225, Ji H Kim, Sang K Yu, Yeon S Seo, Hyung J Yim, Jong E Yeon, Jong J Park, Jae S Kim, Young T Bak, Chang H Lee and Kwan S Byun

    Version of Record online : 27 MAY 2007, DOI: 10.1111/j.1440-1746.2007.04921.x

  19. Randomized, three-arm study to optimize lamivudine efficacy in hepatitis B e antigen-positive chronic hepatitis B patients

    Journal of Gastroenterology and Hepatology

    Volume 30, Issue 4, April 2015, Pages: 748–755, Xieer Liang, Jun Cheng, Yongtao Sun, Xinyue Chen, Tong Li, Hao Wang, Jianning Jiang, Xiaoping Chen, Hui Long, Hong Tang, Yanyan Yu, Jifang Sheng, Shijun Chen, Junqi Niu, Hong Ren, Junping Shi, Xiaoguang Dou, Mobin Wan, Jiaji Jiang, Qing Xie, Guangfeng Shi, Qin Ning, Chengwei Chen, Deming Tan, Hong Ma, Jian Sun, Jidong Jia, Hui Zhuang and Jinlin Hou

    Version of Record online : 16 MAR 2015, DOI: 10.1111/jgh.12835

  20. Long-term lamivudine treatment achieves regression of advanced liver fibrosis/cirrhosis in patients with chronic hepatitis B

    Journal of Gastroenterology and Hepatology

    Volume 30, Issue 2, February 2015, Pages: 372–378, Bei Xu, Lanyi Lin, Guoguang Xu, Yan Zhuang, Qing Guo, Yunye Liu, Hui Wang, Xiaqiu Zhou, Shanming Wu, Shisan Bao, Wei Cai and Qing Xie

    Version of Record online : 24 JAN 2015, DOI: 10.1111/jgh.12718